News
Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...
Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE ...
At first glance, Pfizer delivered a strong Q2 and upped its 2025 full-year EPS guidance. Click here to find out why I rate ...
Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...
PFIZER said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday.
Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results